ClinicalTrials.gg
Status unknownNCT03726970DTAUpdated Jan 23, 2020

Effect of Metal Artifacts Reduction Orotocols and Electric Potential Difference on Metal Artifacts in Cone Beam Computed Tomography

An interventional study of CBCT radiation in Metal Artifacts, sponsored by Cairo University. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2020-01-23.

Sponsored by Cairo University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jan 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Sex
All
01

Study summary

The effect of metal artifacts reduction protocols and tube potential difference on the metallic artifacts in cone beam computed tomography

Read the detailed description

Our study is a quantitative as well as a qualitative assessment of the metal artifacts in the CBCT images in a bio models with multiple adjacent dental implants and single isolated implants , while using different MAR protocols inherited in the CBCT soft ware , as well as change in the tube potential difference of the CBCT unit

02

Conditions studied

  • Metal Artifacts
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • bio models of a lower jaw Titanium implants Porcelain fused to metal crowns

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
2 participants (actual)

Study arms

  • Experimental
    Tube Potential difference

    Different kVp values of the CBCT machine 70, 80 ,90 kVp

    Radiation: CBCT radiation

  • Experimental
    MAR tool

    MAR option in the software off and on

    Radiation: CBCT radiation

Interventions

  • RadiationCBCT radiation

    CBCT scanning

06

What researchers measure

Primary outcomes

  1. Dental implant linear measurement

    The implant length and width in millimeters will be assessed in the presence of the artifacts with and without the activation of the MAR tool of the CBCT soft ware, also change in the potential difference will be done with and without the activation of MAR tool

    Time frame: 1 month

Secondary outcomes

  1. Bone- implant interphase

    Qualitative assessment if bone - implant interphase, will be either zero or 1 zero indicate that bone implant interphase cannot be assessed , one indicate that the bone implant interphase can be assessed

    Time frame: 1 month

07

Study locations

1 site
  • Marina Salib
    Cairo, Giza Governorate 12511, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2018 to primary completion in Oct 2018, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 12, 2018
First posted
Nov 1, 2018
StartActual
Sep 10, 2018
Primary completionActual
Oct 30, 2018
CompletionEst.
Dec 10, 2021
Last update
Jan 23, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03726970
Lead sponsor
Cairo University
Responsible party
Marina Salib (Masters degree student, Cairo University) — Principal investigator
First posted
Nov 1, 2018
Start date
Sep 10, 2018
Primary completion
Oct 30, 2018
Completion
Dec 10, 2021 (estimated)
Last update
Jan 23, 2020

Study contacts

Mushira M Dahba, Doctorate
study director · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion